AusCann is an Australian-based pharmaceutical company focused on the development, production, and distribution of cannabinoid-based medicines within Australia and internationally.

Our key difference is the commitment to a rigorous pharmaceutical development program, focused on providing reliable, stable and standardised cannabinoid-based pharmaceutical products, whilst generating the clinical evidence to support market access.

We have built a strong team of experts and partners with both local and international connections. Our team has the right expertise across all aspects of the pharmaceutical value chain.

Our immediate focus is on providing healthcare professionals with solutions to optimise treatment outcomes for their patients. To do that, we developed an innovative formulation that is contained in a standardised capsule. AusCann’s capsules are designed to enable accurate dosing.  For more information, please visit our website: www.auscann.com.au